Stay updated on ILIxadencel + CPI in Tumors Clinical Trial
Sign up to get notified when there's something new on the ILIxadencel + CPI in Tumors Clinical Trial page.

Latest updates to the ILIxadencel + CPI in Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2 on the page.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the page; no other content or functional changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision tag updated from v3.4.0 to v3.4.1, with no changes to study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check56 days agoChange DetectedMinor UI and metadata updates were made: glossary toggle options (Show glossary / Hide glossary), capitalization tweaks in QC-related text (Last Update Submitted that Met QC Criteria vs Last Update Submitted that met QC Criteria), and a new revision tag (Revision: v3.4.0) with related wording changes (No FEAR Act Data vs No FEAR Act data). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check64 days agoChange DetectedRevision: v3.3.4 is displayed on the page, replacing v3.3.3. This is a minor version update with no changes to the trial details.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page now includes a dedicated Locations section listing Florida, Iowa, Kentucky, North Carolina, and Ohio. The HHS Vulnerability Disclosure link and the former state-specific location sections were removed, and the revision tag was updated to v3.3.3.SummaryDifference0.6%

Stay in the know with updates to ILIxadencel + CPI in Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ILIxadencel + CPI in Tumors Clinical Trial page.